This message was sent to ##Email##
|
|
|
|
|
AST
The AST sponsors a variety of Achievement Awards in recognition of AST members' achievements and contributions to the field of transplantation. The AST encourages members to nominate deserving candidates for consideration. Make your nominations by January 31.
READ MORE
AST
The 2018 COP giving contest: The Donation Derby is under way! Watch this race, as the COPs compete for two prizes and fundraise for their upcoming initiatives. All donations made by COP members until the end of the year will count towards this contest, so be sure to check it out today.
READ MORE
AST
Now through November 30, 2018, the AST is accepting nominations for its 2019 Board of Directors. If you are interested in joining the AST board, or know someone who is, we encourage you to submit your nomination.
READ MORE
 |
|
The Thompson Liver / Oncology System provides surgeons with the ability to obtain stable, versatile retraction for liver transplants, liver resections, oncology, and obesity cases. Multi-planed retraction and unlimited flexibility for the most complex abdominal and pelvic cases. Call 1-800-227-7543 to start your free trial.
|
|
AST
Join us for an interactive discussion on personalized medicine at the 2019 Cutting Edge of Transplantation (CEoT) meeting in Phoenix, AZ. The deadline to submit your abstracts is December 13.
READ MORE
AST
The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Instructions for the application can be found here. The deadline to apply is January 15, 2019. Don't miss out on joining this prestigious program and be recognized for your contributions to transplantation.
|
|
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career – from basic trainee lessons to webinars on specialized topics. LEARN MORE
|
The study is designed to explore an investigational drug-maribavir-in stem cell transplant and solid organ transplant recipients whose CMV infections are not responding to current treatments. This investigational drug is given as an oral pill. Please visit to learn more about the SOLSTICE study.
|
|
|
|
|
The first and only clinically and analytically validated blood test that measures donor-derived cell-free DNA (dd-cfDNA), a direct indicator of kidney injury
Covered by Medicare
AlloSure 101 – Development & Summary Webinar – view
|
|
|
|
|
AST
Comprehensive Trainee Curriculum (CTC) is a great way to expand your transplant knowledge. This feature is an online educational platform that features dozens of webinars on various concentrations of transplantation.
READ MORE
| Upcoming Education Events
|
    |
AST
Psychosocial Aspects of Transition of the Newly Adult, New Patient
November 28, 2018 | 2 pm ET | Online Activity
For more information, click here.
Banff survey on antibody‐mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications
December 4, 2018 | 2 pm ET | Online Activity
For more information, click here.
AST
Significance, Identification and Treatment of Post-Thoracic Transplant Circulating Antibodies
After participating in this webinar, the learner will be able to:
- Describe the significance of post-transplant donor-specific antibodies (DSA) in the lung transplant recipients.
- Discuss techniques used to identify post-transplant DSA in lung transplant recipients.
- Describe possible therapeutic options used in a lung transplant recipient with DSA.
READ MORE
|
The articles included in this email are for informational use only and are not endorsed by the AST.
|
American Journal of Transplantation
Alloimmune risk stratification in renal transplantation has lacked the necessary prognostic biomarkers to personalize recipient care or optimize clinical trials. HLA molecular mismatch improves precision compared to traditional antigen mismatch but has not been studied in detail at the individual molecule level. This study evaluated 664 renal transplant recipients and correlated HLA‐DR/DQ single molecule eplet mismatch with serologic, histologic, and clinical outcomes.
READ MORE
American Journal of Transplantation
Factors that patients value when choosing a transplant center have not been well studied. In order to guide the improvement of patient‐facing materials, we conducted an anonymous electronic survey of patients that assessed the relative importance of patient experience, practical considerations, transplant center reputation, center experience, and waitlist when selecting a transplant center.
READ MORE
American Journal of Transplantation
The Final Rule mandates that organ allocation not be based on the transplant candidate's place of residence or listing, except as required by sound medical judgment and best use of donated organs, to avoid wasting organs and futile transplants, and to promote access and efficiency. Current Organ Procurement and Transplantation Network (OPTN) policies use donation service areas and OPTN regions to distribute and allocate organs for transplant.
READ MORE
Nature News
Liver transplantation is a highly successful treatment, but is severely limited by the shortage in donor organs. However, many potential donor organs cannot be used; this is because sub-optimal livers do not tolerate conventional cold storage and there is no reliable way to assess organ viability preoperatively. Normothermic machine perfusion maintains the liver in a physiological state, avoids cooling and allows recovery and functional testing.
READ MORE
Transplantation
Liver transplantation represents an effective treatment for patients with end-stage liver disease. However, patient access to this lifesaving procedure continues to be limited by the lack of organs resulting into high mortality rates while awaiting transplantation. Attempts to expand the donor pool during the last decade using marginal organs and partial grafts have reached a plateau. At the same time, organ discard rates (organs procured but never transplanted) continue to remain mainly related to the poor quality of donor organs.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
